Open-loop systems eliminate this limitation by providing a shared infrastructure, allowing transactions between different providers while maintaining security, compliance, and affordability.

However, individuals using a hybrid closed-loop system had a higher rate of ketoacidosis (1.74 events per 100 patient-years) than those using open-loop therapy (0.96 per 100 patient-years).